Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins / sulfa (sulfonamides) attending: addendum: transplant surgical service addendum to follow chief complaint: pancreatic/duodenal cancer major surgical or invasive procedure: cesarean delivery whipple blood patch history of present illness: asked to consult on this 40yo wf for suspected pancreatic cancer. patient presented to osh in early with two week complaint of epigastric pain, nausea/vomiting, emesis, early satiety and reflux. patient describes a recent 9 pound weight loss over a two month period. at osh, patient's amylase was noted to be 1032, alt 87, and ast of 37. on u/s patient showed ruq gb sludge and cbd dilatation to 1.7cm. she was admitted to on , placed npo with ivf and her gb percutaneously drained. ercp and bx showed adenocarcinoma at the ampulla of vater with lymphatic involvement. patient is in for same admission after cesarean secion on . patient at time of interview c/o nausea, anorexia, two small bouts of emesis, and no flatus. past medical history: past surgical history: none past ob history: nsvd at term 9#, no complications (home birth) past gyn history: cervical dysplasia s/p laser ablation prenatal course: edc by lmp c/w 1st trimester u/s o+/ab-/rpr nr/ri/hbsag- ama: declined amniocentesis, normal serum screen social history: lives with husband in . nonsmoker. no etoh/drug use. family history: aunt with pancreatic cancer physical exam: at time of interview: gen: alert and oriented x 3; nad heent: nonicteric, no cervical lad cv: rrr lungs: ctab abd: soft, nontender, moderate distension without palpable masses. lower abdominal incision is clean, dry, and intact ext: patient has no clubbing, cyanosis, or edema pertinent results: 06:45am blood wbc-7.8 rbc-3.22* hgb-9.7* hct-28.1* mcv-87 mch-30.2 mchc-34.6 rdw-14.6 plt ct-323 06:32am blood wbc-9.9 rbc-2.89* hgb-9.1* hct-27.3* mcv-95 mch-31.5 mchc-33.3 rdw-14.5 plt ct-237 06:45am blood plt ct-323 06:32am blood plt ct-237 06:45am blood glucose-91 urean-12 creat-0.7 na-140 k-4.4 cl-102 hco3-27 angap-15 06:32am blood glucose-108* urean-13 creat-0.3* na-140 k-3.9 cl-106 hco3-24 angap-14 06:45am blood alt-63* ast-28 alkphos-303* amylase-22 totbili-0.6 06:32am blood alt-71* ast-30 alkphos-140* amylase-135* totbili-1.2 06:45am blood lipase-9 06:00am blood lipase-75* 06:45am blood albumin-3.3* 06:32am blood albumin-2.7* calcium-8.3* phos-3.1 mg-1.9 06:32am blood triglyc-127 mri: lesion within the pancreatic head along the right, involving the ampulla and duodenal wall concerning for primary carcinoma of either the periampular region (pancreas versus duodenum) or ectopic pancreas within the duodenum. cxr: no acute cardiopulmonary abnormality pathology: gb- chronic cholecystitis, with cholesterolosis. 2. no calculi or tumor pancreas- 1. adenocarcinoma of the pancreatic head; see synoptic report. 2. chronic inactive duodenitis with marked hyperplasia at the ampulla. 3. marked dilation of the common bile duct. 4. chronic pancreatitis with fibrosis and dilated pancreatic duct. g2: moderately differentiated, pt3: tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery. pn1b: metastasis in multiple regional lymph nodes. lymph nodes number examined: eight (8). number involved: three (3). distant metastasis: pmx: cannot be assessed.margins: margins uninvolved by invasive carcinoma: distance from closest margin: 4 mm. perineural, lymphatic, and venous involvement all present t-tube study -flow of contrast from the intrahepatic biliary tree into the small bowel without apparent hold up or obstruction. no contrast extravasation brief hospital course: patient care taken over from ob/gyn service on after cesearean section post-op care. patient transferred to the west campus and preop'ed for whipple procedure on (hd10). patient tolerated the procedure well and was admitted to the icu for acute post-operative care. patient had hct of 31.5 on pod1, but required fluid boluses to maintain urine output; patient had good pain control with epidural. patient was transferred to the transplant surgery floor on . patient developed headache on while getting out of bed to a chair, aps following patient recommended caffeine and bedrest, as patient obtaining good pain relief with epidural. routine post-op care was continued on , with continued ha, but good pain relief with epidural. patient remained without flatus but appropriate urine output while remaining af with stable vs. to prevent future ha, aps discontinued the epidural on and a blood patch placed through the old epidural site. ngt was removed on the same day and patient placed on sips with good tolerance. patient was walking on and diet was advanced, with clearance by pt obtained as patient fully ambulatory. patient obtained t-tube cholangiogram on with above mentioned results and amylase of 19 obtained. patient was advanced to full regular renal diet on with capped t-tube, and jp drain removed. patient weaned off of tpn started in prepartum period, and lft's continued to trend downward, while patient monitored on for increased po intake. kub was obtained to evaluate for possible obstruction or ileus, but was wnl. patient discharged home on with good po intake, appropriate ambulation, and good po pain control medications on admission: reglan, anzemet, morphine, pepcid discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 2. acetaminophen-caff-butalbital mg tablet sig: tablets po q4-6h (every 4 to 6 hours) as needed: do not exceed 6 tabs per day. disp:*56 tablet(s)* refills:*0* 3. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q12h (every 12 hours). disp:*60 tablet, delayed release (e.c.)(s)* refills:*2* 4. hydromorphone 2 mg tablet sig: one (1) tablet po q4h (every 4 hours) as needed: breakthrough pain. disp:*30 tablet(s)* refills:*0* 5. metoclopramide 10 mg tablet sig: one (1) tablet po tid (3 times a day) as needed for delayed gastric emptying. disp:*42 tablet(s)* refills:*1* 6. anzemet 50 mg tablet sig: one (1) tablet po every eight (8) hours as needed for nausea. disp:*30 tablet(s)* refills:*2* 7. ultram 50 mg tablet sig: 1-2 tablets po every 4-6 hours as needed for pain. disp:*30 tablet(s)* refills:*0* discharge disposition: home discharge diagnosis: cesarean delivery mechanical gi obstruction cholangiocarcinoma spinal headache discharge condition: stable discharge instructions: call if fevers, chills, nausea,vomiting, inability to take medications, increased abdominal pain, worsening headache, jaundice, redness/pus/drainage from t.tube or any questions. labs weekly followup instructions: , md, phd: date/time: 2:00 please call with any questions or to reschedule your appointment md, procedure: parenteral infusion of concentrated nutritional substances radical pancreaticoduodenectomy insertion of other (naso-)gastric tube cholecystectomy incision of adrenal gland low cervical cesarean section other cholangiogram spinal blood patch diagnoses: secondary malignant neoplasm of other specified sites malignant neoplasm of head of pancreas obstruction of bile duct secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes secondary malignant neoplasm of other digestive organs and spleen chronic cholecystitis acquired hypertrophic pyloric stenosis secondary malignant neoplasm of small intestine including duodenum early onset of delivery, delivered, with or without mention of antepartum condition other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn reaction to spinal or lumbar puncture breech presentation without mention of version, delivered, with or without mention of antepartum condition 

Answer: The patient is high likely exposed to